| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/01/1992 | WO1992003471A1 New insulin-like growth factor binding protein igfbp-5 |
| 03/01/1992 | WO1992003470A1 Genetic material encoding igfbp-5 |
| 03/01/1992 | WO1992003469A1 Genetic material encoding igfbp-4 |
| 03/01/1992 | WO1992003152A1 New insulin-like growth factor binding protein (igfbp-4) |
| 03/01/1992 | CA2090705A1 Genetic material encoding igfbp-5 |
| 03/01/1992 | CA2090704A1 Genetic material encoding igfbp-4 |
| 03/01/1992 | CA2090703A1 Insulin-like growth factor binding protein (igfbp-4) |
| 03/01/1992 | CA2090702A1 Insulin-like growth factor binding protein igfbp-5 |
| 03/01/1992 | CA2090620A1 Methods of treating, diagnosing and monitoring therapies from levels of human oubain-like factor and antibody thereof |
| 03/01/1992 | CA2090478A1 Human interferon- 4-134, functional equivalents thereof and methods of using and compositions employing these materials |
| 03/01/1992 | CA2090470A1 Peptide antigens and immunoassays, test kits and vaccines using the same |
| 03/01/1992 | CA2089761A1 Method and compositions for diagnosing and treating chronic fatique immunodysfunction syndrome |
| 03/01/1992 | CA2072105A1 Mutation of hrv2 2a |
| 03/01/1992 | CA2050451A1 Dna and polypeptide for tumor-associated antigen co-029 |
| 03/01/1992 | CA2050063A1 Polyethylene glycol derivatives, their modified peptides, methods for producing them and use of the modified peptides |
| 03/01/1992 | CA2049883A1 Monoclonal antibody specifically reactive with human perforin |
| 03/01/1992 | CA2048309A1 Method and compositions for inhibiting aminoglycoside nephrotoxicity |
| 02/28/1992 | WO1992003538A1 METHODS FOR PRODUCING RNA VIRUSES FROM cDNA |
| 02/28/1992 | WO1992003473A1 Cd18 peptide medicaments for the treatment of disease |
| 02/28/1992 | WO1992003459A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 02/28/1992 | WO1992003145A1 Method of treating viral infection |
| 02/28/1992 | CA2090486A1 Human zona pellucida protein zp3 |
| 02/28/1992 | CA2090469A1 Ligand for the c-kit receptor and methods of use thereof |
| 02/28/1992 | CA2090427A1 Cd18 peptide medicaments for the treatment of disease |
| 02/28/1992 | CA2090401A1 Method of treating viral infection |
| 02/27/1992 | DE4026964A1 New infectious acid-resistant rhinovirus strain - is e.g. mutant of serotype 14; for treating rhinovirus infection |
| 02/26/1992 | WO1992003458A1 Non-a, non-b hepatitis virus antigen, diagnostic methods and vaccines |
| 02/26/1992 | EP0472494A2 Anti-pathogenic biocontrol agents, genes encoding antibiotics synthesis and the use of said antibiotics |
| 02/26/1992 | EP0472434A2 Antisense oligonucleotides complementary to the macromolecular synthesis operon of bacteria, and their uses in diagnosis and therapy |
| 02/26/1992 | EP0472399A2 HLA-DR antigen gene, its nucleotide sequence and its use |
| 02/26/1992 | EP0472286A1 Gene encoding candida albicans plasma membrane H+ATPase |
| 02/26/1992 | EP0472207A2 Hepatitis C assay utilizing recombinant antigens |
| 02/26/1992 | EP0471804A1 Novel human cyclin a compositions and their production method, a corresponding nucleotide sequence, a method and agents for detecting or diagnosing cell multiplication, and a method and agents for inhibiting cell multiplication |
| 02/26/1992 | EP0471793A1 Improved forms of basic fibroblast growth factor |
| 02/26/1992 | EP0471787A1 A plasmid dna construct including the gene encoding a mammalian beta-nerve growth factor |
| 02/26/1992 | EP0471778A1 Herpes simplex virus type 2-glycoprotein g proteins and polypeptides |
| 02/26/1992 | EP0471759A1 HIGH LEVEL EXPRESSION OF FUNCTIONAL HUMAN PLASMINOGEN ACTIVATOR INHIBITOR (PAI-1) IN $i(E. COLI) |
| 02/26/1992 | EP0471752A1 Polypeptides of feline t-cell lymphotropic lentivirus |
| 02/26/1992 | EP0471687A1 Methods and nucleic acid sequences for the expression of the cellulose synthase operon |
| 02/26/1992 | EP0247145B1 Multiply-amplifiable vectors for high level expression of exogenous dna |
| 02/26/1992 | EP0218712B1 Novel procoagulant proteins |
| 02/26/1992 | CN1058990A Protein structure of plant toxin gelonin |
| 02/26/1992 | CA2090335A1 Non-a, non-b hepatitis virus antigen, diagnostic methods and vaccines |
| 02/25/1992 | US5091518 Beta retinoic acid response elements compositions and assays |
| 02/25/1992 | US5091511 Lymphokine activated killer suppressive factor (LAKSF), process for producing it and immunosuppressive agent comprising it |
| 02/25/1992 | US5091368 Biologically active compounds from blue-green algae |
| 02/25/1992 | US5091367 Analogs of gonadoliberin with improved solubility, methods for their preparation, agents containing them and their use |
| 02/25/1992 | US5091366 Natriuretics, hypotensive agents |
| 02/25/1992 | US5091364 Preparation of immunologically active cell wall components from archaebacteria |
| 02/25/1992 | US5091309 Sindbis virus vectors |
| 02/25/1992 | US5091303 Binding of monoclonal antibody to pure p29 protein |
| 02/25/1992 | US5091302 Polymorphism of human platelet membrane glycoprotein iiia and diagnostic and therapeutic applications thereof |
| 02/25/1992 | US5091177 Monoclonal antibodies for treatment of human non-small cell lung carcinomas |
| 02/25/1992 | US5091173 Hair growth composition |
| 02/25/1992 | CA1296486C Therapeutic peptides |
| 02/25/1992 | CA1296278C Cell surface modification using a novel glycoproteinase of pasteurella haemolytica |
| 02/25/1992 | CA1296273C Recombinant methods for production of serine protease inhibitors and methods for isolation of same |
| 02/25/1992 | CA1296271C Promoter arrangement for streptomycetes vectors |
| 02/24/1992 | WO1992003158A1 Nucleotide and amino acid sequences of protein mtp40 of m. tuberculosis and synthetic peptides derived therefrom |
| 02/24/1992 | CA2089888A1 Nucleotide and amino acid sequences of protein mtp40 of m. tuberculosis and synthetic peptides derived therefrom |
| 02/24/1992 | CA2049538A1 Chondromodulin-i protein |
| 02/21/1992 | WO1992003735A1 Liver fluke diagnostic system |
| 02/21/1992 | CA2089157A1 Liver fluke diagnostic system |
| 02/21/1992 | CA2067337A1 Methods for producing rna viruses from cdna |
| 02/21/1992 | CA2049401A1 Heparin binding neurotrophic factor gene sequence |
| 02/21/1992 | CA2049385A1 Anti-pathogenic biocontrol agents, genes encoding antibiotics synthesis and the use of said antibiotics |
| 02/21/1992 | CA2049370A1 Human mk gene and protein sequence |
| 02/20/1992 | WO1992002822A1 Methods for the identification of cytokine convertase inhibitors |
| 02/20/1992 | WO1992002820A1 Monoclonal antibody to enterohemorrhagic escherichia coli 0157:h7 and 026:h11 and method for detection |
| 02/20/1992 | WO1992002626A1 Eliminating internal initiation of soluble cd4 gene |
| 02/20/1992 | WO1992002624A1 Cloning and expression of toxoplasma antigens and use of recombinant antigens |
| 02/20/1992 | WO1992002623A1 CLONING AND EXPRESSION OF A RHOPTRY ASSOCIATED PROTEIN OF $i(P.FALCIPARUM) |
| 02/20/1992 | WO1992002620A1 Chimeric neurotrophic factors |
| 02/20/1992 | WO1992002618A1 Animal models for thrombopathies and cardiopathies |
| 02/20/1992 | WO1992002615A1 Serine protease variants having peptide ligase activity |
| 02/20/1992 | WO1992002612A2 Tissue plasminogen activator variants with decreased clearance |
| 02/20/1992 | WO1992002558A1 Method of purifying cytokeratin 20, and the use of cytokeratin 20 to produce antibodies |
| 02/20/1992 | WO1992002557A1 arg A HUMAN GENE RELATED TO BUT DISTINCT FROM abl PROTO-ONCOGENE |
| 02/20/1992 | WO1992002556A1 Human colon cancer cell-derived fibroblast elongation factor |
| 02/20/1992 | WO1992002555A1 A fibronectin binding peptide |
| 02/20/1992 | WO1992002554A1 Nuclear phosphoproteins for prognosticating lymphoid or epithelial cancers |
| 02/20/1992 | WO1992002553A1 Tumor cell binding molecule with protease inhibiting region |
| 02/20/1992 | WO1992002552A1 Granulocyte-inhibiting polypeptide |
| 02/20/1992 | WO1992002550A1 Expression of recombinant polypeptides with improved purification |
| 02/20/1992 | WO1992002548A1 Recombinant baculovirus expressing proteins e and ns1 of flaviviridae viruses and flaviviridae-related viruses |
| 02/20/1992 | WO1992002544A1 Peptides of the chromostatin family |
| 02/20/1992 | WO1992002543A1 Novel immunosuppressant peptides |
| 02/20/1992 | WO1992002541A1 Biologically active compounds from blue-green algae |
| 02/20/1992 | WO1992002539A1 Process for the enzymatic preparation of basic fibroblast growth factor |
| 02/20/1992 | WO1992002537A1 Method for preparing a peptide having growth factor activity, a product thereby obtained, and uses thereof as a drug |
| 02/20/1992 | WO1992002529A1 Expression vectors regulated by estrogen and a mutant estrogen receptor |
| 02/20/1992 | WO1992002527A1 New carbohydrate-based anti-inflammatory agents |
| 02/20/1992 | WO1992002252A1 The gene encoding equine herpesvirus type 1 glycoprotein d, its gene product, antibodies and their uses |
| 02/20/1992 | WO1992002250A1 Cross-reactive influenza a immunization |
| 02/20/1992 | WO1992002246A1 Growth factor compositions, preparation and use |
| 02/20/1992 | WO1992002237A1 Analogs of endothelin |
| 02/20/1992 | WO1992002236A1 Agent for preventing and treating hepatitis |
| 02/20/1992 | WO1992002228A1 Viral (hiv) growth inhibition |
| 02/20/1992 | WO1992002142A1 High viscosity bacteria, bacterial compositions, and methods |
| 02/20/1992 | WO1992002139A1 Insecticidal proteins |